Azurity Pharms., Inc. v. Alkem Labs. Ltd. Firvanq® (Vancomycin)

Case Name: Azurity Pharms., Inc. v. Alkem Labs. Ltd., No. 20-cv-1094, 2023 WL 3254117 (D. Del. May 4, 2023) (Goldberg, J.) Drug Product and Patent(s)-in-Suit: Firvanq® (vancomycin); U.S. Patent No. 10,959,948 (“the ’948 patent”)….
By: Robins Kaplan LLP